Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1981 Feb;72(2):233–237. doi: 10.1111/j.1476-5381.1981.tb09118.x

5-Hydroxytryptamine induces relaxation of goat pulmonary veins: evidence for the noninvolvement of M and D-tryptamine receptors.

N Chand
PMCID: PMC2071513  PMID: 7214093

Abstract

1 Reactivity of goat isolated pulmonary arteries and veins to a variety of vasoactive agents was investigated. 2 Bradykinin (Bk), acetylcholine (ACh), noradrenaline (NA), prostaglandin A1 (PGA1), PGE2, PGF2 alpha and histamine induced dose-dependent contractile responses on veins; 5-hydroxytryptamine (5-HT) induced veno-relaxation. Angiotensin was virtually inactive. 3 Angiotensin, NA, Bk, histamine and 5-HT produced concentration-dependent contractile responses on the arterial strips; these arteries failed to respond to ACh, PGA1, PGE2 or PGF2 alpha. 4 The pulmonary veno-relaxant response to 5-HT was found to be resistant to propranolol, indomethacin, metiamide, cimetidine, methysergide, atropine and morphine. These findings appear to exclude the involvement of adrenergic mechanisms and prostaglandin generation as well as activation of classical M and D-tryptamine receptors by 5-HT in the goat pulmonary veins. This response may be mediated via a presynaptic inhibitory 5-HT receptor. 5 5-HT-induced arterial contractile responses were antagonized by methysergide, showing the occurrence of classical D receptors in the goat pulmonary artery. 6 It is concluded that differential reactivity of pulmonary arteries and veins to vasoactive agents may play differential role(s) in the pathophysiology of pulmonary disease. 5-HT may exert an antiinflammatory activity in goat pulmonary veins.

Full text

PDF
233

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alabaster V. A., Bakhle Y. S. Release of smooth muscle-contracting substances from isolated perfused lungs. Eur J Pharmacol. 1976 Feb;35(2):349–360. doi: 10.1016/0014-2999(76)90238-7. [DOI] [PubMed] [Google Scholar]
  2. Carlson J. R., Dyer I. A., Johnson R. J. Tryptophan-induced intersitial pulmonary emphysema in cattle. Am J Vet Res. 1968 Oct;29(10):1983–1989. [PubMed] [Google Scholar]
  3. Carlson J. R., Yokoyama M. T., Dickinson E. O. Induction of pulmonary edema and emphysema in cattle and goats with 3-methylindole. Science. 1972 Apr 21;176(4032):298–299. doi: 10.1126/science.176.4032.298. [DOI] [PubMed] [Google Scholar]
  4. Chand N., DeRoth L., Eyre P. Relaxant response of goat trachea to 5-hydroxy-tryptamine mediated by D-tryptamine receptors. Br J Pharmacol. 1979 Jun;66(2):331–336. doi: 10.1111/j.1476-5381.1979.tb13684.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Eyre P. Atypical tryptamine receptors in sheep pulmonary vein. Br J Pharmacol. 1975 Nov;55(3):329–333. doi: 10.1111/j.1476-5381.1975.tb06935.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Eyre P. Comparisons of reactivity of pulmonary vascular and airway smooth muscle of sheep and calf to tryptamine analogues, histamine, and antigen. Am J Vet Res. 1975 Aug;36(08):1081–1084. [PubMed] [Google Scholar]
  7. Eyre P. Pharmacology of bovine pulmonary vein anaphylaxis in vitro. Br J Pharmacol. 1971 Oct;43(2):302–311. [PMC free article] [PubMed] [Google Scholar]
  8. Feniuk W., Humphrey P. P., Watts A. D. Presynaptic inhibitory action of 5-hydroxytryptamine in dog isolated saphenous vein. Br J Pharmacol. 1979 Oct;67(2):247–254. doi: 10.1111/j.1476-5381.1979.tb08673.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. GADDUM J. H., HAMEED K. A., HATHWAY D. E., STEPHENS F. F. Quantitative studies of antagonists for 5-hydroxytryptamine. Q J Exp Physiol Cogn Med Sci. 1955 Jan;40(1):49–74. doi: 10.1113/expphysiol.1955.sp001097. [DOI] [PubMed] [Google Scholar]
  10. GADDUM J. H., PICARELLI Z. P. Two kinds of tryptamine receptor. Br J Pharmacol Chemother. 1957 Sep;12(3):323–328. doi: 10.1111/j.1476-5381.1957.tb00142.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hanna C. J., Eyre P. Pharmacological studies on the pulmonary vein of the horse. I. Effects of selected spasmogens. Can J Physiol Pharmacol. 1978 Oct;56(5):812–817. doi: 10.1139/y78-127. [DOI] [PubMed] [Google Scholar]
  12. Joiner P. D., Kadowitz P. J., Davis L. B., Hyman A. L. Contractile responses of canine isolated pulmonary lobar arteries and veins to norepinephrine, serotonin, and tyramine. Can J Physiol Pharmacol. 1975 Oct;53(5):830–838. doi: 10.1139/y75-114. [DOI] [PubMed] [Google Scholar]
  13. McGrath M. A. 5-hydroxytryptamine and neurotransmitter release in canine blood vessels. Inhibition by low and augmentation by high concentrations. Circ Res. 1977 Oct;41(4):428–435. doi: 10.1161/01.res.41.4.428. [DOI] [PubMed] [Google Scholar]
  14. Sadavongvivad C. Pharmacological significance of biogenic amines in the lungs: 5-hydroxytryptamine. Br J Pharmacol. 1970 Feb;38(2):353–365. doi: 10.1111/j.1476-5381.1970.tb08523.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Somlyo A. P., Somlyo A. V. Vascular smooth muscle. II. Pharmacology of normal and hypotensive vessels. Pharmacol Rev. 1970 Jun;22(2):249–353. [PubMed] [Google Scholar]
  16. Su C., Bevan J. A. Pharmacology of pulmonary blood vessels. Pharmacol Ther B. 1976;2(2):275–288. doi: 10.1016/s0306-039x(76)80009-8. [DOI] [PubMed] [Google Scholar]
  17. Vargaftig B. B., Lefort J. Pharmacological evidence for a vasodilator receptor to serotonin in the nasal vessels of the dog. Eur J Pharmacol. 1974 Feb;25(2):216–225. doi: 10.1016/0014-2999(74)90053-3. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES